Searched for
ZEJULA
GSK India plans big 'reinvention', MD Bhushan Akshikar revealsGlaxoSmithKline Pharmaceuticals is planning a major comeback in India. The company aims to double its revenue to ₹8,000 crore within the ne...- GSK re-enters India’s cancer drug marketGlaxoSmithKline Pharmaceuticals is re-entering India's oncology market with the launch of Jemperli and Zejula, precision therapies for gyna...
- GSK enters into oncology segment; launches therapies for gynaecological cancersGlaxoSmithKline Pharmaceuticals has entered the oncology segment in India, introducing Jemperli and Zejula for gynaecological cancers. Thes...
- Will PLI help Indian pharma gain market share at cost of MNCs?Indian pharmaceutical companies are becoming more aggressive and increasing their market share and capex. Companies such as Divis, Dr Reddy...
- Week that was: 10 stocks that kept D-Street buzzing through the weekShares of Hindustan Zinc, which recently announced a massive Rs 13,985 crore dividends fell 10 per cent during the week as the scrip turned...
- Dishman Pharma rallies 15% despite clarification on Zejula capsulesThe stock gained 15.56% to hit a high of Rs 321.50 on BSE.
- Dishman Pharma zooms 20% as merger with arms becomes effectiveFollowing the announcement, the stock hit its upper circuit limit of 20 per cent at Rs 278.20 on BSE.
Load More